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Abstract
Introduction: Findings regarding the association between overweight and all-cause mortality range from significantly lower
to higher risk, compared with body-mass-index (BMI) within the ‘‘normal’’ range.
Methods: We examined empirically potential methodological explanations for these apparently conflicting results using
questionnaire and linked mortality data from 246,314 individuals aged $45 years in the Australian 45 and Up Study (11,127
deaths; median follow-up 3.9 years). Hazard ratios (HR) for all-cause mortality associated with BMI were modelled according
to different methods of accounting for illness at baseline, finer versus broader gradations of BMI and choice of reference
group, adjusting for potential confounders.
Results: In analyses using the broad World Health Organization (WHO) categories, the all-cause mortality HR was
significantly lower in the overweight category (25.0–29.99 kg/m2), than the normal weight (18.5–24.99 kg/m2) category.
However, in analyses accounting for baseline illness, which excluded those with pre-existing illness at baseline, ever-
smokers and the first 2 years of follow up, absolute age-standardised mortality rates varied up to two-fold between finer
BMI categories within the WHO normal weight category; rates were lowest at 22.5–24.99 kg/m2 and mortality HRs increased
steadily for BMI above (ptrend,0.02) and below (ptrend,0.003) this reference category. Hence, the breadth of the BMI
categories used and whether or not baseline illness is accounted for explain the apparent discrepancies between reported
BMI-mortality associations.
Conclusion: Using fine BMI categories and the category with the lowest absolute rates as the reference group and
accounting for the potential confounding effects of baseline illness is likely to yield the most reliable risk estimates for
establishing the independent relationship of BMI to all-cause mortality. These results and those of other studies indicate
that a BMI of 22.5–24.99 kg/m2, not the broad ‘‘overweight’’ category of 25–29.99 kg/m2, was associated with the most
favourable mortality risk.
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Introduction
With the distribution of body mass index (BMI) shifting upwards
in many populations [1], the epidemic of overweight and obesity is
now recognised as one of the most important public health
problems that the world faces today. At least half the population of
most high-income countries is currently overweight or obese [2]
and more than 4% of the burden of disease in these countries is
directly attributable to high BMI [3].
The association between obesity, defined as having a BMI of
30 kg/m2 or more, and increased risk of death, overall and from
heart disease, stroke, and certain cancers is well established [4,5].
Publications based on broad groupings of BMI and meta-analyses
of published data have found significantly lower death rates among
people with BMI in the World Health Organization (WHO)
category of ‘‘overweight’’ (BMI 25.0–29.9) compared to those with
BMI in the broad ‘‘normal’’ range (BMI 18.5–24.9[6–8] or 20–
24.9[9]). In apparent contrast, large-scale studies of individual
participant data, with fine gradations in BMI, have shown that the
risk of all-cause mortality is lowest in individuals with a BMI of
22.5–24.9 (i.e. within the normal range) and is significantly higher
in those with BMIs both above and below this level [4,10,11]. This
has led to questions about the ideal BMI for longevity and
speculation about the potential protective properties of being
overweight or slightly obese [12,13]. Further, pre-existing disease
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at baseline and smoking are associated with both decreased BMI
and an increased risk of death [14], and studies have varied in the
extent to which they have addressed this [15].
This paper uses prospective data from a large cohort of
Australian adults aged 45 years and over to explore the extent to
which methodological issues may influence quantification of the
relationship of BMI to all-cause mortality. It aims to investigate the
impact on estimates of absolute and relative risk of: (i) the inclusion
or exclusion of individuals with pre-existing disease at baseline and
those who ever smoked; (ii) the size of the BMI categories used; (iii)
the fineness of age adjustment; and (iv) the degree of adjustment
for potential confounding factors. A secondary aim is to provide
evidence informing the likely BMI level associated with the lowest
all-cause mortality.
Materials and Methods
The 45 and Up Study is a cohort study of 267,153 men and
women aged 45 years and over, randomly sampled from the
general population of New South Wales (NSW), Australia.
Individuals joined the study by completing a postal questionnaire
(distributed from 1 February 2006 to 31 December 2008) and
giving informed consent for follow-up through repeated data
collection and linkage of their data to population health databases.
The study methods are described in detail elsewhere [16]. The 45
and Up Study is fully owned and managed by the Sax Institute.
Questionnaires and data access policies are available at https://
www.saxinstitute.org.au/our-work/45-up-study/governance/.
Baseline questionnaire data include information on socio-
demographic and lifestyle factors, height and body weight, medical
and surgical history, functional capacity and physical activity. BMI
was calculated from self-reported body weight and height, as
weight in kilograms divided by the square of height in metres.
Deaths among study participants were ascertained from the
New South Wales Registry of Births, Deaths and Marriages for the
period 1 January 2006 to 30 June 2012; the Registry provides data
on fact of death and date of death for all deaths in NSW. The
mortality data were linked probabilistically to the baseline
questionnaire data from the 45 and Up Study by the Centre for
Health Record Linkage.
Statistical methods
Excluding 376 (0.15%) participants with invalid age and/or
date of recruitment, data from 266,777 participants from the 45
and Up Study were linked to data on fact of death. Consistent with
established methods [4], people with extreme measures of BMI (,
15 kg/m2 or BMI.50 kg/m2) were excluded due to the increased
probability of measurement error. After excluding people with
missing or invalid BMI (n = 20,441; 7.7%) and confirmed linkage
errors (n = 22; 0.01%), data on 246,314 participants were available
for the main analyses.
The main outcome was defined as all-cause mortality following
recruitment into the 45 and Up Study. Eligible participants
contributed person-years from the date of recruitment until date of
death or end of follow-up (30 June 2012), whichever was the
earliest.
In order to explore the extent to which methodological issues
might influence quantification of the relationship of BMI to all-
cause mortality, a series of analyses were conducted. To investigate
the potential impact on hazard ratio (HR) estimates of baseline
illness, leading to both weight loss and increasing mortality
(sometimes termed reverse causality [17]), ‘all participant’ analyses
were performed with no exclusions; and then ‘healthy participant’
analyses were performed, which excluded those reporting on the
baseline questionnaire a doctor-diagnosis of heart disease, stroke,
blood clot or cancer other than melanoma and skin cancer, or
having ever smoked, and also excluded the first 2 years of follow
up. Recommended approaches to reduce bias introduced by
smokers and participants with pre-existing illnesses involve
restricting the analysis to subjects who have never smoked and
excluding deaths that occur during the first several years of follow-
up (possibly as a result of conditions that caused lower weights at
baseline) respectively [10].
BMI categorisation and the choice of reference category are
likely to play important roles in the evaluation of the BMI-
mortality relationship [18]. All-cause mortality rates and 95%
confidence intervals (95% CI) were calculated for different levels of
BMI using two different categorisations of BMI [19]: (i) broad
categorisation (WHO weight classification in brackets): 15–18.49
(underweight); 18.5–24.99 (normal weight); 25–29.99 (overweight);
30–50 kg/m2 (obese); and (ii) finer categorisation of BMI (WHO
weight classification in brackets): 15–18.49 (underweight); 18.5–
19.99, 20–22.49 and 22.5–24.99 (normal weight); 25–27.49 and
27.5–29.99 (overweight); 30–34.99 (obese class I); and 35–50 kg/
m2 (obese class II-III).
Mortality rates for males and females were calculated separately
and were age-standardised to the 2006 NSW population, in 5 year
age-groups, using the direct method [20].
HRs for all-cause mortality according to BMI at baseline were
estimated using Cox regression modelling, in which the underlying
time variable was age. For the broad BMI categorisation, we used
the WHO normal weight category as the reference group for the
HR estimates, consistent with previous publications [6]. For the
finer BMI categorisation, we used the lowest age-standardised rate
in the healthy participant analyses as the reference group. The HR
and 95%CI are shown initially accounting for age, the underlying
time variable. A sensitivity analysis examined the type of age
adjustment: as a categorical covariate in 5-year groups, as a
continuous covariate, or as the underlying time variable. Models
are also presented adjusted for additional covariates (where
appropriate) including, alcohol consumption [alcoholic drinks/
week 0, 1–14, $15], annual pre-tax household income [AUD ,
$20,000, $20,000–$39,999, $40,000–$69,999, $$70,000], educa-
tion [,secondary school graduation, secondary school graduation,
trade/apprenticeship/certificate/diploma, university degree or
higher], region of residence [major cities, inner regional areas,
outer regional/remote areas] and health insurance [private health
insurance yes/no]. No adjustment was made for physical activity,
high blood pressure or high blood cholesterol as these are among
the likely mechanisms in the pathway linking body weight and
mortality. Missing values for covariates were included in the
models as separate categories, which included alcohol consump-
tion 4,771 (1.9%), annual pre-tax household income 51,553 (4.9%
missing; 16% declined to answer), education 3,537 (1.4%), region
of residence 55 (0.02%) and health insurance 7 (,0.01%).
The proportionality assumption of Cox regression was verified
by plotting the Schoenfeld residuals against the time variable in
each model, with a stratified form or time-dependent form of the
model used where covariates displayed non-proportionality of
hazards. In addition to estimating the category-specific HRs, we
estimated the HR associated with each 5 kg/m2 increase in BMI
for BMIs greater than or equal to the lowest cut-point of the BMI
category with the lowest mortality rate, and we also modelled the
median BMI for categories as a continuous variable. Tests for
trend in the risk of mortality with increasing BMI were done using
these models. Martingale residual plots were used to verify the
linear functional form of BMI, where BMI was modelled as a
continuous variable.
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All statistical tests were two sided, using a significance level of
5%. All analyses were carried out using SASH version 9.3 [21].
Ethical approval for the study was obtained from the NSW
Population and Health Services Research Ethics Committee and
the Australian National University Human Research Ethics
Committee.
Results
The study population was aged between 45 and 110 years at
baseline, with a mean of 63 [SD 11]. The majority of participants
(61%) were aged 45–64 years with 10% aged 80 years or older;
just under half the cohort (47%) comprised men (Table 1). Nearly
two-thirds (62%) were overweight or obese (40% and 22%,
respectively), with obesity prevalence substantially lower in those
aged $ 80 years (12%). The mean BMI was 26.9 [SD 4.9] kg/m2.
The median follow-up time for the cohort was 3.9 years (mean 4.2
years); a total of 11,127 deaths occurred during 1,042,270 person-
years of follow up (1,463 deaths occurred during 248,785 person-
years of follow up among healthy participants).
The age-standardised rates of all-cause mortality, calculated
using the broad WHO categorisation of BMI, were higher in men
than in women at all levels of BMI. When all participants were
included, the lowest mortality rates were observed in the broad
overweight BMI category of 25–29.99 kg/m2 for both sexes
[deaths per 1000 p-years (95% CI) of 10.1 (9.7–10.5) and 5.8 (5.4–
6.1) for men and women respectively; Figure 1a, 1b]. The absolute
rates were significantly lower in the healthy participant analysis
but the pattern across broad BMI categories remained similar
except that there was a greater reduction in the rates among
underweight males and females than in the other BMI categories.
In the analyses with broad BMI categorisation, HRs were
estimated using the ‘‘normal weight’’ BMI category (18.5–
24.99 kg/m2) as the reference group. When all participants were
included, the age-adjusted HR of all-cause mortality was
significantly lower in the overweight category among both sexes
compared with the corresponding normal weight category (HR
(95% CI): 0.83 (0.79–0.87) and 0.82 (0.76–0.88) standardised for
men and women, respectively) and was significantly higher in the
obese category (1.13 (1.05–1.21) and 1.10 (1.01–1.20) for men and
women, respectively) and in the underweight category (2.23 (1.92–
2.60) and 2.03 (1.79–2.31) for men and women, respectively)
(Figure 2a, 2b). The pattern remained similar when the data were
restricted to healthy participants.
When age-standardised rates and HRs were re-calculated using
finer categories of BMI, an up to two-fold variation in the all-cause
mortality rates within the WHO normal weight category (BMI
18.5–24.99 kg/m2) became evident (Figure 1c, 1d, 2c, 2d). When
all participants were included in the analysis, the age-standardised
rates and HR were lowest in the fine BMI category of 25-
27.49 kg/m2 [deaths per 1000 p-years (95% CI) of 9.8 (9.3–10.3)
and 5.6 (5.2–6.1); HR (95% CI): 0.91 (0.85–0.98) and 0.93 (0.84–
1.03) among males and females respectively]. When analyses were
restricted to the healthy participants, the lowest age-standardised
rates were observed in BMI category 22.5–24.99 kg/m2, which
was then used as the reference category. The HR (95% CI) of
mortality increased steadily above and below the reference
category of BMI 22.5–24.99 kg/m2, with a HR of 1.46 (1.29–
1.65) and 1.23 (1.10–1.37) per 5 kg/m2 increase in BMI among
males and females respectively [for BMI 22.5 kg/m2 upwards, p-
trend ,0.0001 for males and p-trend= 0.0002 for females (Figure
2c, 2d)].
Compared with models where age is the underlying time
variable and is automatically adjusted for, models with age as a
continuous covariate or as a categorical covariate resulted in little
variation in the HR estimates (Table 2). Adjusting additionally for
region of residence, household income, education, alcohol intake
and health insurance also resulted in little change in the overall
pattern of results, with the greatest change seen in the HRs in the
35–50 kg/m2 group (Table 3).
Discussion
In this large prospective population-based cohort study,
substantial variation in the relationship of BMI to all-cause
mortality was observed according to whether or not individuals
with pre-existing disease at baseline were included in the analysis,
Table 1. Characteristics of study population according to body mass index (BMI) category at baseline.
BMI (kg/m2) at baseline
15–18.49 18.5–19.99 20–22.49 22.5–24.99 25–27.49 27.5–29.99 30–34.99 35–50 Total
n 3103 6842 30185 53738 55661 41740 39307 15738 246314
Mean age (SD) 67 (14) 63 (13) 63 (12) 63 (12) 63 (11) 62 (10) 62 (10) 60 (9) 63 (11)
Male 25 22 32 45 55 57 49 35 47
Tertiary education 21 27 28 27 25 22 19 16 24
Household income $ $70,000 13 21 24 25 26 25 23 20 24
Highest physical activity tertile 35 37 39 37 35 32 27 22 33
$ 15 alcoholic drinks/week 9 8 10 13 16 17 16 11 14
Residing in major cities 48 51 49 48 45 43 42 39 45
Current smokers 17 11 9 7 6 6 7 7 7
Past smokers 26 27 30 34 37 40 41 40 36
History of cancer 15 12 12 11 11 11 11 11 11
History of CVD 18 12 12 14 15 16 16 17 15
Data are percentage of sample within BMI category unless indicated otherwise.
A history of cardiovascular disease (CVD) at baseline was defined as self-reported heart disease, stroke or blood clot on the baseline questionnaire.
A history of cancer at baseline was defined as self-reported history of cancer other than melanoma and skin cancer on the baseline questionnaire.
doi:10.1371/journal.pone.0088641.t001
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the coarseness of BMI categories used and the reference BMI
category chosen.
Using broad BMI categorisation among all participants and
among healthier participants, the lowest mortality rates were
observed in the WHO overweight BMI category of 25–29.99 kg/
m2. However, when age-standardszed rates and HRs were re-
calculated using finer categories of BMI, an up to two-fold
variation was observed within the WHO normal weight category.
With finer BMI categories, the category at which the rates and
HR were lowest varied according to whether or not individuals
with pre-existing disease at baseline were included in the analysis
(25–27.49 kg/m2 when all participants were included; 22.5–
24.99 kg/m2 when individuals with pre-existing disease at
baseline, ever-smokers and the first 2 years of follow-up were
excluded). When individuals with pre-existing disease at baseline,
ever-smokers and the first two years of follow up were excluded
Figure 1. All-cause mortality rates (95% CI) per 1000 person-years by sex and differing BMI categories, directly age-standardised to
2006 New South Wales population. Rates plotted at median body mass index (BMI) for the categories: broad categorisation 15–18.49, 18.5–
24.99, 25–29.99, 30–50 kg/m2; finer categorisation 15–18.49, 18.5–19.99, 20–22.49, 22.5–24.99, 25–27.49, 27.5–29.99, 30–34.99, 35–50 kg/m2. The
healthy participants analysis excludes those who ever smoked at baseline, those with a history of CVD at baseline (defined as self-reported heart
disease, stroke or blood clot on the baseline questionnaire) and those with a history of cancer at baseline (defined as self-reported history of cancer
other than melanoma and skin cancer on the baseline questionnaire), and excludes the first 2 years of follow-up.
doi:10.1371/journal.pone.0088641.g001
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from analyses and finer BMI categories were used, there was at
least a 25% linear increase in the risk of all-cause mortality for
every 5 unit increase in BMI, from BMI 22.5 kg/m2 onwards. The
coarseness of age adjustment or adjusting additionally for other
potential confounders, including region of residence, household
Figure 2. Hazard ratio estimates for all-cause mortality by sex and differing BMI categories. Hazard ratios (HRs), adjusted for age as the
underlying time variable, are plotted on log-scale at median body mass index (BMI) for the categories: broad categorisation 15–18.49, 18.5–24.99
(reference), 25–29.99, 30–50 kg/m2; finer categorisation 15–18.49, 18.5–19.99, 20–22.49, 22.5–24.99 (reference), 25–27.49, 27.5–29.99, 30–34.99, 35–
50 kg/m2. 95% CIs are indicated by vertical lines. The healthy participants analyses excludes those who ever smoked at baseline, those with a history
of cardiovascular disease at baseline (defined as self-reported heart disease, stroke or blood clot on the baseline questionnaire) and those with a
history of cancer at baseline (defined as self-reported history of cancer other than melanoma and skin cancer on the baseline questionnaire), and
excludes the first 2 years of follow-up.
doi:10.1371/journal.pone.0088641.g002
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income, education, alcohol intake and health insurance, did not
materially modify the results.
We are not aware of any previous large-scale studies that have
investigated empirically the factors underlying the apparently
conflicting results on the association between BMI and mortality.
A study based on 11,000 people from the National Population
Health Survey of Canada examined findings for both broad and
finer categorisation of BMI, included covariate adjustment for
smoking status and performed sensitivity analyses excluding the
first four years of follow-up to account for baseline illness.
However, power was limited, particularly for the finer categories of
BMI, and the analysis pertaining to finer categorisation of BMI did
not account for baseline illness [8]. Nevertheless, our findings
relating to the relationship of BMI for broad [6,8,22] and fine
categorisations of BMI [4,11,23,24] generally agree with the
published evidence for each of these categorisation types,
respectively. Similarly, our findings for analyses that do and do
not take account of baseline illness and smoking status are also
consistent with published studies [4,6,11,23,24].
Particularly worth noting is the recent meta-analyses of
published data, using broad categories of BMI [6] and recent
pooled analyses of individual participant data, using fine BMI
categories [4] [11]. The meta-analysis using broad WHO BMI
categories [6] based on 2.88 million participants and .270 000
deaths reported that, compared with normal BMI, overweight was
associated with significantly lower all-cause mortality [HR (95%
Table 2. Sensitivity analysis for coarseness of age adjustment: Hazard ratio estimates (95% CI) for all-cause mortality among
healthy participants.
Male Female
BMI Model 1 Model 2 Model 3 Model 1 Model 2 Model 3
15–18.49 1.94 (1.10– 3.41) 2.06 (1.17– 3.62) 1.95 (1.10– 3.44) 2.04 (1.43– 2.90) 2.02 (1.42– 2.88) 1.97 (1.38– 2.81)
18.5–19.99 1.89 (1.24– 2.88) 1.94 (1.28– 2.96) 1.89 (1.24– 2.88) 1.80 (1.34– 2.42) 1.77 (1.32– 2.38) 1.72 (1.28– 2.32)
20–22.49 1.54 (1.22– 1.94) 1.53 (1.21– 1.93) 1.52 (1.20– 1.92) 1.42 (1.13– 1.78) 1.44 (1.15– 1.80) 1.43 (1.14– 1.80)
22.5–24.99 1.00 1.00 1.00 1.00 1.00 1.00
25–27.49 0.99 (0.80– 1.23) 1.00 (0.81– 1.24) 1.02 (0.82– 1.26) 1.00 (0.79– 1.27) 1.01 (0.80– 1.28) 1.01 (0.80– 1.28)
27.5–29.99 1.10 (0.86– 1.42) 1.09 (0.85– 1.39) 1.11 (0.87– 1.42) 1.08 (0.83– 1.40) 1.08 (0.83– 1.40) 1.09 (0.84– 1.42)
30–34.99 1.52 (1.18– 1.96) 1.51 (1.17– 1.95) 1.56 (1.21– 2.02) 1.22 (0.94– 1.58) 1.24 (0.96– 1.62) 1.27 (0.98– 1.66)
35–50 2.78 (1.93– 4.00) 2.85 (1.98– 4.10) 2.91 (2.02– 4.19) 1.81 (1.29– 2.53) 1.86 (1.33– 2.60) 1.87 (1.34– 2.62)
Excludes those who ever smoked at baseline, those with a history of cardiovascular disease at baseline (defined as self-reported heart disease, stroke or blood clot on
the baseline questionnaire), those with a history of cancer at baseline (defined as self-reported history of cancer other than melanoma and skin cancer on the baseline
questionnaire) and the first two years of follow up.
Model 1: Follow up time is the underlying time variable, age adjusted for as categorical variable in 5-year groups.
Model 2: Follow up time is the underlying time variable, age adjusted for as continuous variable.
Model 3: Age adjusted for as the underlying time variable.
doi:10.1371/journal.pone.0088641.t002
Table 3. Sensitivity analysis for additional covariate adjustment: Hazard ratio estimates (95% CI) for all-cause mortality among
healthy participants.
Male Female
BMI Deaths Crude rate HR1 HR2 Deaths Crude rate HR1 HR2
15–18.49 13 30.16 1.95 (1.10–3.44) 1.85 (1.04– 3.27) 39 15.83 1.97 (1.38–2.81) 1.93 (1.35– 2.76)
18.5–19.99 25 20.57 1.89 (1.24–2.88) 1.84 (1.20– 2.81) 62 9.79 1.72 (1.28–2.32) 1.74 (1.29– 2.35)
20–22.49 122 14.63 1.52 (1.20–1.92) 1.49 (1.18– 1.88) 152 5.99 1.43 (1.14–1.80) 1.45 (1.16– 1.82)
22.5–24.99 171 7.67 1.00 1.00 150 4.23 1.00 1.00
25–27.49 157 5.85 1.02 (0.82–1.26) 0.99 (0.80– 1.23) 129 4.34 1.01 (0.80–1.28) 1.01 (0.80– 1.28)
27.5–29.99 101 5.26 1.11 (0.87–1.42) 1.08 (0.84– 1.38) 87 4.22 1.09 (0.84–1.43) 1.06 (0.81– 1.38)
30–34.99 95 6.78 1.56 (1.21–2.02) 1.45 (1.12– 1.88) 90 4.06 1.27 (0.98–1.66) 1.21 (0.93– 1.57)
35–50 36 9.30 2.91 (2.02–4.19) 2.61 (1.81– 3.78) 45 4.26 1.87 (1.34–2.62) 1.66 (1.18– 2.33)
5 unit increase from 1.46 1.41 1.23 1.17
BMI 22.5 kg/m2 (1.29–1.65) (1.25–1.60) (1.10–1.37) (1.05–1.31)
Crude rates are per 1000 person-years.
HR1: Hazard ratio (HR) adjusted for age (underlying time variable).
HR2: Hazard ratio (HR) adjusted for age (underlying time variable), region of residence, household income, education, alcohol intake and health insurance.
Excludes those who ever smoked at baseline, those with a history of cardiovascular disease at baseline (defined as self-reported heart disease, stroke or blood clot on
the baseline questionnaire) and those with a history of cancer at baseline (defined as self-reported history of cancer other than melanoma and skin cancer on the
baseline questionnaire) and the first two years of follow up.
doi:10.1371/journal.pone.0088641.t003
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CI) 0.94 (0.91–0.96)], class one obesity (BMI 30.0–34.9) did not
differ significantly [0.95 (0.88–1.01)] and classes 2 and 3 obesity
(BMI $35) were associated with significantly increased mortality
[1.29 (1.18–1.41)]. In this meta-analysis, where individual data
were not available, adjustments for confounding factors were
possible only by excluding whole studies. The authors stated that
the results did not change materially when smokers and those with
a history of cancer or heart disease were excluded [5].
In both the pooled analyses based on fine BMI categorisation
[4,11], the lowest death rates were observed for BMI in the normal
weight range. Since individual data were available, these analyses
allowed covariate adjustments and restrictions. The Prospective
Studies Collaboration combined individual data on 900,000 adults
from 57 prospective studies, adjusting for smoking and excluding
person-years and deaths in the first five years from the main
analyses, to limit the effect of baseline illnesses [4]. They
concluded that all-cause mortality increased with increasing fine
categories of BMI beyond a BMI of 22.5 kg/m2 and that the
lowest death rates were observed for BMI 22.5 to 24.9 kg/m2 in
both sexes. They noted the potential for the BMI with the lowest
underlying death rates to be even lower than this, if the influence
of weight loss secondary to disease were to be eliminated
completely. The other analysis based on pooled individual data
from 19 prospective studies, which included 1.46 million white
adults, restricted their data to participants who never smoked and
were not diagnosed with cancer or heart disease [11]. It also
concluded that both overweight and obesity were associated with
increased all-cause mortality, with lowest mortality in the BMI
range of 20.0 to 24.9 kg/m2. Hence, although the methods of
dealing with baseline illness differed between the two pooled
analyses, their findings were consistent.
Based on our study as well as previous literature, the central
questions relevant to quantifying the ideal BMI for longevity
include: (i) how should BMI be categorised? and (ii) should
baseline illness be accounted for?
First, let us consider the statistical implications of categorising a
continuous variable in regression analyses. When categorising a
continuous variable, one assumes that the relation between the
independent and the dependent variable is constant within each
interval, since any change in effect within an interval will not be
quantified [25], even a biologically plausible one. Statistical
efficiency increases with the number of categorical groups
[26,27] and is usually greatest using a continuous analysis
(assuming that assumptions such as linearity are satisfied). More
practical considerations, however, may favour categorisation for
ease of interpretation and may be motivated by use of clinically
relevant cut-off points [28]. In the case of the previously
mentioned meta-analysis of published data, categorisation accord-
ing to WHO groups was necessary since these were the categories
used in the original publications [6].
Are categories based on WHO BMI cut-offs a good choice
when looking at the association between BMI and mortality? In
1999, the Expert Committee of WHO [29] proposed a BMI
classification with cut-offs of 25, 30, 35 and 40 kg/m2 in adults for
Pre-obesity, Obesity classes I, II, and III respectively, based
principally on initial analyses of the association between BMI and
mortality. The main basis of the WHO BMI classification [29]
were two papers: the first paper was a 1997 publication by Gill
[30], which included a figure adapted from the Nurses’ Health
study [10], demonstrating that when biases are removed from
analysis, an almost linear, continuous relationship between BMI
and mortality is found, with no specific lower threshold; the second
was a review paper by the American Institute of Nutrition, which
concluded that the lowest mortality is seen at BMI 18–25 kg/m2
[31]. In the Nurses’ Health study, (based on women aged 30–55
years, followed up for 16 years from 1976), BMI,19 was used as
the reference group for relative risk estimation. Bias from reverse
causality was limited by restricting analyses to: women who never
smoked, with weight change of not more than 4 kg from 1976–
1980, who were free of known cardiovascular disease and cancer,
and by excluding the first four years of follow-up.
Estimating the regression coefficients for levels of a categorical
predicator involves specification of an appropriate reference
category against which the other categories are compared [32],
especially for nominal categorical predictors [33]. Both the
biological interpretation of the estimated association and the
number of observations should be considered when choosing the
reference category [25]. Although the Expert Committee of WHO
defined 18.50–24.99 kg/m2 as the normal range for BMI, it was
also noted that the broad ranges of BMI do not imply that an
individual can fluctuate within this range without consequence; for
example, for an individual 1.75 m tall, the BMI range of 18.50–
24.99 covers a weight range of 20 kg. The Expert Committee of
WHO had also identified BMI standards for the elderly (.60 or.
80 years) as a priority area for future research. The observed
variations within the WHO normal weight category BMI 18.5–
24.99 kg/m2 indicate that it is too broad to be a suitable reference
category in the analysis of BMI and mortality, especially for studies
that include older people aged 60+ years. Modelling BMI as a
continuous variable employing regression techniques that use
restricted cubic splines is likely to be of interest for future analyses,
but is beyond the scope of the current paper, which seeks to
explain the differences between published findings on BMI and
mortality [34].
People frequently lose weight as a result of an illness that is
ultimately fatal, a situation that creates the appearance of higher
mortality among those with lower weights [14] and the leanest
group in a population is a mix of smokers, people who have lost
weight as a result of underlying disease, and people who have
maintained a lean weight by balancing physical activity and caloric
intake [14]. Because both BMI and mortality are likely to vary in a
graded manner with the severity of pre-existing illness, simple
binary adjustment for the presence or absence of disease will not
adequately deal with such confounding. It follows that people who
have lost weight due to illness are likely to be distributed across the
BMI spectrum and it is difficult, if not impossible, to estimate the
independent effects on mortality of high BMI in people who are ill.
In prospective studies, the best analytic approach depends on
what is already known across a variety of disciplines about the
relationship under examination and the statistical implications of
analytical choices. Inadequate control for pre-existing illness and
smoking status can distort the true relation between body weight
and the risk of death because chronic illness and smoking are
associated with both decreased BMI and an increased risk of death
[14]. Suggested strategies [14] for prospective studies to address
the issue of bias due to pre-existing baseline illness are: excluding
participants with diagnoses that might affect weight; excluding
participants who report recent weight loss (such as during the
previous five years) [10]; and excluding deaths that occur during
the first several years of follow-up (possibly as a result of conditions
that caused lower weights at baseline) [10]. Restricting the analysis
to participants who have never smoked [10] or reporting the
results in subgroups of smoking status are other strategies.
Concerns regarding accounting for pre-existing illness at baseline
have been raised citing weak evidence of occurrence of bias,
disproportionate exclusion of overweight/obese participants,
insufficient evidence regarding the adjustment strategies about
their validity and systematic effects on relative risks [35]. However,
Overweight and Mortality Paradox: A Closer Look
PLOS ONE | www.plosone.org 7 February 2014 | Volume 9 | Issue 2 | e88641
evidence based on simulation studies [17] and large prospective
studies [24,36] have demonstrated that bias is introduced by
inclusion of participants with pre-existing illnesses and it needs to
be accounted for. Furthermore, this study has demonstrated that
excluding people with baseline illness results in substantive effects
on the estimates of the BMI-mortality relationship with fine BMI
categorisation, but not with broad BMI categorisation. If there
really was no bias due to reverse causality or confounding by
baseline illness, one would expect comparable results in people
with and without baseline illness and consistent results regardless
of exclusion of people with baseline illness. The WHO classifica-
tion of BMI [29] is also based on a study [10] which accounted for
pre-existing illness at baseline and smoking.
Use of the standard broad BMI categories in the analysis of
BMI and mortality may appear to facilitate between-study
comparisons and make decision making in a clinical setting
simpler. However, a major drawback of the use of broad BMI
categorisation is that the statistical assumption of a constant
relationship within intervals in the categories of continuous
variables is violated. Large variations in absolute rates and two-
fold variation in the HR of death were observed within the broad
normal BMI category (which the WHO had cautioned about),
indicating that the relation between mortality and BMI is not
constant within the normal BMI category.
It should be borne in mind that the WHO BMI categories were
originally defined based on evidence from an observational study
and the WHO group themselves noted potential for revision of the
cut-offs, should evidence indicative of a need for change emerge
[29]. Indeed, the categories have been revised downwards for
Asian populations [37].
Analytic strategies to minimise bias due to pre-existing illness at
baseline, use of finer BMI categories and analysis restricted to
participants who never smoked are likely to yield estimates of BMI
and mortality relationship that are more reliable for estimating the
likely independent effects of BMI in the population. Ideally the
reference group for finer categories should be the group with the
lowest absolute mortality rate among healthy participants;
however, studies which include people aged over 60 years require
careful consideration due to possible high prevalence of pre-
existing illnesses at baseline.
Finally, a model with time-on-study, adjusting for age as a
continuous variable, assumes that age has a log-linear association
with the hazard at study entry. It also assumes that the effect of
follow-up time is similar across the different ages (e.g. the
proportional increase in the hazard over one year is the same
for someone aged 45 years and 85 years). Further, variability in the
age-at-entry of individuals in the study could cause the models to
differ significantly [38], even when age is adjusted for [39]. These
assumptions and problems can be avoided with the use of age as
the underlying time scale. Even though it is computationally
intensive in practice, using age as the time scale gives more
accurate results because it puts similar subjects in the risk set
together and allows a completely non-parametric age effect [40].
Alternatively, age could be modelled as a non-linear predictor,
employing regression techniques that use restricted cubic splines.
When analysing studies with longer follow up times, it should also
be noted that none of the above mentioned approaches take
cohort effects into account and the potential for the BMI-mortality
relationship to vary across birth cohorts cannot be excluded.
Major strengths of this study are: (i) its large sample size (which
means that we were able to make the appropriate exclusions and
stratification), (ii) the availability of a range of potential confound-
ers measured at baseline, allowing covariate adjustments, and (iii)
virtually complete follow up data on death. However, due to the
relatively short follow up period at the time of analysis, we were
only able to exclude the first two years of follow up to control for
sources of bias arising from pre-existing disease at baseline. BMI
was calculated using self-reported weight and height and data on
potential confounding factors were mostly based on self-report.
Regarding self-reported BMI, although people tend to underes-
timate their weight and overestimate their height [41], and
consequently underestimate BMI, a validation study involving
participants in the 45 and Up Study revealed that the mean
difference between self-reported and measured BMI was not large
(on average –0.74 kg/m2) and correlations between self-reported
and measured height and weight were 0.95 and 0.99, respectively
[42]; results which are consistent with other studies. Other
measures of adiposity, such as those relating to central obesity,
were not ascertained in our study. The independent effect of BMI
may be slightly overestimated as factors such as physical activity
will also exert an independent effect on mortality. The central
purpose of this paper is not the definitive quantification of the risk
of mortality according to BMI, but to demonstrate the potential
differences in results depending on methodological choices. It is
important to refer to studies with appropriate statistical power and
accounting for BMI measurement error, for example [4], for
statistically reliable evidence on the BMI-mortality relationship.
In conclusion, evidence from this study indicates that investi-
gations of the relationship between BMI and mortality could easily
arrive at opposing conclusions on the mortality risk of being
overweight but not obese, depending on the coarseness of BMI
categories used and the measures implemented to control bias. We
have demonstrated that study exclusions to minimise bias (pre-
existing illness at baseline and smoking), coarseness of BMI
categorisation and choice of reference category had a significant
impact on the relative hazard estimates. Paradoxical associations
suggesting a beneficial association of overweight with mortality
were observed in models where sources of bias were inadequately
controlled and broad categories of BMI were used. If BMI is
modelled as a categorical variable in the analyses of mortality risks
in relation to BMI, the use of fine classification of BMI is
recommended, along with strategies to minimise bias due to pre-
existing illness and factors such as smoking.
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